Next-Generation Sequencing in Metastatic Breast Cancer: A Game Changer for Asian Patients
This study, led by N2CR members Dr Joline Lim and A/Prof David Tan, looks at the use of next-generation sequencing (NGS) for molecular profiling of metastatic breast cancer (MBC) in […]